April 4, 2019
Gent, BELGIË – 4 april 2019 – Sequana Medical NV (Euronext Brussels: SEQUA), een onderneming in medische toestellen die zich in de commerciële fase bevindt en zich richt op vernieuwende behandelingsoplossingen om leveraandoeningen, hartfalen, maligne ascites en andere vochtbalansproblemen te behandelen, publiceert vandaag haar bedrijfshoogtepunten en financiële resultaten per 31 december 2018, die werden opgesteld in overeenstemming...
Read More

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our
Privacy & Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.